Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade Non-Muscle Invasive Bladder Cancer After BCG Failure (BOND2)

Clinical Trial ID NCT02365818

PubWeight™ 4.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02365818

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recent advances in oncolytic adenovirus therapies for cancer. Curr Opin Virol 2016 0.87
2 Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses. Mol Ther Methods Clin Dev 2016 0.86
3 Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer Sci 2016 0.86
4 Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology 2015 0.83
5 Oncolytic virotherapy for urological cancers. Nat Rev Urol 2016 0.76
Next 100